About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 69 record(s)
Req # A-2021-002003
The Canada Gazette, Part I, Volume 155, Number 25: Order Amending Schedules 2 and 3 to the Tobacco and Vaping Products Act (Flavours) REGULATORY IMPACT ANALYSIS STATEMENT refers to the elicitation of estimates of the risk of vaping compared to smoking from five academics. The process used to elicit this information. A report on eliciting the experts' opinion, analogous to "Elicitation of Expert Judgements on the Behavioural Aspects of a Nicotine Standard" March 2017. Any report or documentation referring to how information on the risks of vaping was elicited from the five academics.Organization: Health Canada
April 2022
Req # A-2021-002004
Grants or other payments have Health Canada made to Physicians for a Smoke-Free Canada from Jan 1st, 2021 to Feb 24th, 2022. The purpose of each payment or grant. What did Health Canada receive in return for the payment or grant?Organization: Health Canada
April 2022
Req # A-2021-002020
List of the organizations, excluding sole proprietorships and partnerships, that have been distributed free rapid tests through the COVID-19 free rapid testing program from its launch, until Jan 27th, 2022Organization: Health Canada
April 2022
Req # A-2021-002066
The exact number of individuals who's deaths were reported to Health Canada in 2020 where antipsychotic medication was listed at the primary suspect. Of these deaths involving antipsychotics, the number of individuals who died from a completed suicide. The exact number of individuals who's deaths were reported to Health Canada in 2020 where antidepressant medication was listed as the primary suspect.Organization: Health Canada
April 2022
Req # A-2019-002086
Adverse Drug Reactions (ADR). Report Number: E2B_02748990.Organization: Health Canada
April 2022
Req # A-2020-001596
Adverse Drug Reaction (ADR). Report number: E2B_03279279.Organization: Health Canada
April 2022
Req # A-2021-001229
Adverse Drug Reactions (ADRs) for GLYCERYL TRINITRATE. Report numbers: E2B_03929973, E2B_03919695.Organization: Health Canada
April 2022
Req # A-2021-001646
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: 04460246, E2B_03706333.Organization: Health Canada
April 2022
Req # A-2021-001680
Adverse Drug Reaction (ADR) for Glyceryl Trinitate. Report number: E2B_04384481.Organization: Health Canada
April 2022
Req # A-2021-001795
Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_04413148.Organization: Health Canada
April 2022